BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16616891)

  • 41. DeltaNp63 transcriptionally regulates ATM to control p53 Serine-15 phosphorylation.
    Craig AL; Holcakova J; Finlan LE; Nekulova M; Hrstka R; Gueven N; DiRenzo J; Smith G; Hupp TR; Vojtesek B
    Mol Cancer; 2010 Jul; 9():195. PubMed ID: 20663147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polyploid giant cells provide a survival mechanism for p53 mutant cells after DNA damage.
    Illidge TM; Cragg MS; Fringes B; Olive P; Erenpreisa JA
    Cell Biol Int; 2000; 24(9):621-33. PubMed ID: 10964452
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Twenty years of p53 research: structural and functional aspects of the p53 protein.
    May P; May E
    Oncogene; 1999 Dec; 18(53):7621-36. PubMed ID: 10618702
    [No Abstract]   [Full Text] [Related]  

  • 44. The p53 homologue DeltaNp63alpha interacts with the nuclear factor-kappaB pathway to modulate epithelial cell growth.
    King KE; Ponnamperuma RM; Allen C; Lu H; Duggal P; Chen Z; Van Waes C; Weinberg WC
    Cancer Res; 2008 Jul; 68(13):5122-31. PubMed ID: 18593911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ΔNp63α transcriptionally represses p53 target genes involved in the radiation-induced DNA damage response : ΔNp63α may cause genomic instability in epithelial stem cells.
    Kudo KI; Tsuyama N; Nagata K; Imaoka T; Iizuka D; Sugai-Takahashi M; Muramatsu M; Sakai A
    Radiat Oncol; 2022 Nov; 17(1):183. PubMed ID: 36380314
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential enhancement of a cutaneous HPV promoter by DeltaNP63alpha, Jun and mutant p53.
    Fei JW; Wei QX; Angel P; de Villiers EM
    Cell Cycle; 2005 May; 4(5):689-96. PubMed ID: 15846070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ultraviolet radiation induces phosphorylation and ubiquitin-mediated degradation of DeltaNp63alpha.
    Westfall MD; Joyner AS; Barbieri CE; Livingstone M; Pietenpol JA
    Cell Cycle; 2005 May; 4(5):710-6. PubMed ID: 15846104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutant p53 mediates survival of breast cancer cells.
    Lim LY; Vidnovic N; Ellisen LW; Leong CO
    Br J Cancer; 2009 Nov; 101(9):1606-12. PubMed ID: 19773755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dominant negative (DeltaN) p63alpha induces drug resistance in hepatocellular carcinoma by interference with apoptosis signaling pathways.
    Mundt HM; Stremmel W; Melino G; Krammer PH; Schilling T; Müller M
    Biochem Biophys Res Commun; 2010 May; 396(2):335-41. PubMed ID: 20403333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SATB2 augments ΔNp63α in head and neck squamous cell carcinoma.
    Chung J; Lau J; Cheng LS; Grant RI; Robinson F; Ketela T; Reis PP; Roche O; Kamel-Reid S; Moffat J; Ohh M; Perez-Ordonez B; Kaplan DR; Irwin MS
    EMBO Rep; 2010 Oct; 11(10):777-83. PubMed ID: 20829881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. To die or not to die: neurons and p63.
    Miller FD; Kaplan DR
    Cell Cycle; 2007 Feb; 6(3):312-7. PubMed ID: 17264677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dual regulation of TERT activity through transcription and splicing by DeltaNP63alpha.
    Vorovich E; Ratovitski EA
    Aging (Albany NY); 2008 Dec; 1(1):58-67. PubMed ID: 20157588
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brca2 deficiency in the murine small intestine sensitizes to p53-dependent apoptosis and leads to the spontaneous deletion of stem cells.
    Hay T; Patrick T; Winton D; Sansom OJ; Clarke AR
    Oncogene; 2005 May; 24(23):3842-6. PubMed ID: 15735671
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [p53-independent signaling pathway in DNA damage-induced cell apoptosis].
    Zhang X; Jiang Y; Yang J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Mar; 42(2):217-23. PubMed ID: 23585010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p63, cellular senescence and tumor development.
    Guo X; Mills AA
    Cell Cycle; 2007 Feb; 6(3):305-11. PubMed ID: 17224650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The roles of p63 in cancer.
    Flores ER
    Cell Cycle; 2007 Feb; 6(3):300-4. PubMed ID: 17264676
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of ΔNp63α by NFκΒ.
    Sen T; Chang X; Sidransky D; Chatterjee A
    Cell Cycle; 2010 Dec; 9(24):4841-7. PubMed ID: 21088498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. hHR23B is required for genotoxic-specific activation of p53 and apoptosis.
    Kaur M; Pop M; Shi D; Brignone C; Grossman SR
    Oncogene; 2007 Feb; 26(8):1231-7. PubMed ID: 16924240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SMG1 and CDK12 Link ΔNp63α Phosphorylation to RNA Surveillance in Keratinocytes.
    Bamberger C; Pankow S; Yates JR
    J Proteome Res; 2021 Dec; 20(12):5347-5358. PubMed ID: 34761935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. p53-Mediated Activities in NS-5 Neural Stem Cells: Effects of Ethanol.
    Miller MW
    Alcohol Clin Exp Res; 2019 Apr; 43(4):655-667. PubMed ID: 30748015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.